Emergency Department Visits and Hospitalizations for Buprenorphine Ingestion by Children — United States, 2010–2011

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Lovegrove, Maribeth ; Hampton, Lee M. ; Budnitz, Daniel S. ; Geller, Andrew I.
• Description:
  Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to reduce the morbidity and Mortality associated with opioid abuse, and buprenorphine has become an increasingly prescribed component of office-based treatment. However, unsupervised ingestion of buprenorphine-containing products by children is a growing concern.
• Subjects:
  Analgesics, Opioid Buprenorphine Child, Preschool Eating Emergency Service, Hospital Hospitalization Humans Infant Notes From The Field
• Source:
  MMWR Morbidity Mortal Weekly Rep. 2013; 62(3):56.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  23344700
• Pubmed Central ID:
  PMC4604875
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  1 pdf page
• Volume:
  62
• Issue:
  3
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:bd4c342d6f89136fd4dfef0a85d55e661108e99e91e816df55f65ed1f63e3063408b0435855aa64ff5a2c3aff1849bb0cb3724c1659dfaf45a305584f99b016a
• Download URL:
  https://stacks.cdc.gov/view/cdc/54464/cdc_54464_DS1.pdf
• File Type:
  [PDF - 91.63 KB ]